Bristol-Myers Squibb (BMY) Q4 2022 Earnings Call Transcript

Bristol-Myers Squibb (BMY) Q4 2022 Earnings Call Transcript

At this time, I would like to welcome everyone to the Bristol-Myers Squibb fourth quarter 2022 earnings conference call. Joining me this morning with prepared remarks are Giovanni Caforio, our board chair and chief executive officer; and David Elkins, our chief financial officer.